News & Updates

In this interview, AONN+ Board of Trustees member Andi Dwyer discusses the American Cancer Society’s updated colorectal cancer screening guidelines, including new stool-based tests and the first-ever recommendation of an FDA-approved blood-based screening test, while emphasizing that colonoscopy and stool tests remain the most effective tools for early detection and prevention.

Candice Roth, MSN, RN, CENP, and Monica Dean represented AONN+ at the launch of the first U.S. CAR T Vision to Action Blueprint, a stakeholder-driven initiative that provides practical strategies and tools to address access barriers and expand the use of CAR T-cell therapy for eligible patients nationwide by 2030.

AONN+ Board Member Andrea (Andi) Dwyer helped lead a three-year collaboration with the CDC and policymakers that resulted in new ICD-10 codes for Lynch Syndrome, BRCA1, BRCA2, and Li-Fraumeni Syndrome, improving coverage and access to genetic testing and diagnostic services for patients.

AONN+ encourages oncology navigators to complete a brief Commission on Cancer survey that will help shape future navigation program development, identify emerging trends, and strengthen support for the oncology navigation community.

AONN+ Midyear 2026 brought the oncology navigation community together for four days of connection, innovation, and practical insights that are shaping the future of patient care.

Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, recently traveled to Philadelphia to represent AONN+ at the Access USA Conference, specifically for Patient Assistance & Access Programs. Here, she took part in the highly popular panel, “The Medicare Patient Experience: Affordability, Access, and the State of Healthcare Today,” which focused on financial burdens that patients with chronic illnesses face and why the work to improve access is far from finished. 

April 3, 2025 – The undersigned cancer organizations, which represent people with cancer; cancer health care professionals; researchers; and caregivers, families and friends of those with cancer, issued the following statement in response to the mass reductions in force at the Department of Health and Human Services (HHS) and the reorganization of the department.

In recent years, patients with chronic conditions, including cancer, have faced harmful "copay diversion programs" such as copay accumulators and maximizers. These programs prevent copay assistance payments from counting toward a patient's annual deductible and out-of-pocket maximums. Once the assistance runs out, patients are left with hundreds or thousands of out-of-pocket costs, even though they should have already reached their yearly maximum.